Final Programme 2019

39 WORLD FEDERATION SCIENTIFIC PROGRAMME Sunday, 28 April 2019 PL-03 Plenary Session 08:30–10:30 Auditorium I Update on treatment of ADHD over the life-span Chairs: J. Boavida, Portugal C. Soutullo, Spain PL-03-001 Advances in non-pharmacological treatments (food and nutrition-based interventions, non-invasive deep brain stimulation etc.) S. Cortese, United Kingdom PL-03-002 What comes next? The medication pipeline for treatment of ADHD J. Newcorn, USA PL-03-003 Psychosocial and psycho-behavioural treat- ments (cognitive behavioural therapy, psychoeducation) M. Döpfner, Germany PL-03-004 How to approach rational treatment of ADHD comorbidity T. Banaschewski, Germany 10:30 – 11:00 Coffee Break LN-03 Late Breaking News 10:30–11:00 Pavilion 4 Chairs: A. Caye, Brazil K. Ellison, USA LN-03-001 Psychosis with methylphenidate or am- phetamine in patients with ADHD S. Cortese, United Kingdom (Supported by an unrestricted grant from MEDICE) PL-04 Plenary Session 11:00–13:00 Auditorium I Future directions in ADHD Chairs: P. Riederer, Germany L. A. Rohde, Brazil PL-04-001 ICD-11, DSM-5 revised version, RDoC: What is the future of ADHD diagnosis? L. A. Rohde, Brazil PL-04-002 New strategies in modelling ADHD in humans and animals K.-P. Lesch, Germany PL-04-003 Strategic longitudinal examination of the brain at-risk to bring the concepts of early intervention and prevention to ADHD F. X. Castellanos, USA PL-04-004 The promise of digital health for the treat- ment of ADHD S. H. Kollins, USA Closing Ceremony 13:00–13:30 Auditorium I e Congress summary e Presentation of the poster price winners e Announcement of the 8 th ADHD World Congress 2021 www.escap.eu REGISTER NOW! 18 th International Congress of ESCAP VIENNA 2019 DEVELOPMENTAL PSYCHIATRY IN A GLOBALIZED WORLD 30 June – 2 July 2019 | Hofburg Vienna, Austria

RkJQdWJsaXNoZXIy Mzg2Mjgy